Literature DB >> 8810631

National Asthma Education and Prevention Program working group report on the quality of asthma care.

L Headrick1, E Crain, D Evans, M N Jackson, B H Layman, R M Bogin, M Young, K B Weiss.   

Abstract

The quality of asthma care is the second topic of the National Asthma Education and Prevention Program Task Force Report on the Cost Effectiveness, Quality of Care, and Financing of Asthma Care. This working group recommended an asthma continuous quality improvement model as an appropriate framework for examining the quality of asthma care. This model can be implemented by various organizations and providers of care in a variety of settings. The framework consists of four steps: (1) define the opportunity for improvement, (2) set the asthma quality improvement goals (outcomes), (3) characterize the process of care, and (4) begin the improvement cycle. Several case studies are presented to illustrate the use of this model in various settings, including managed care facilities, emergency departments, teaching hospitals, physician's offices, schools, workplaces, and communities. In addition, the appendix provides an overview of asthma outcome measures in the framework of patient-centered versus organizationally based perspectives.

Entities:  

Mesh:

Year:  1996        PMID: 8810631     DOI: 10.1164/ajrccm/154.3_Pt_2.S96

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  3 in total

1.  Comparison of indicators assessing the quality of drug prescribing for asthma.

Authors:  C C Veninga; P Denig; L G Pont; F M Haaijer-Ruskamp
Journal:  Health Serv Res       Date:  2001-04       Impact factor: 3.402

Review 2.  Interprofessional working and continuing medical education.

Authors:  L A Headrick; P M Wilcock; P B Batalden
Journal:  BMJ       Date:  1998-03-07

3.  Defining localities of inadequate treatment for childhood asthma: a GIS approach.

Authors:  Ronit Peled; Haim Reuveni; Joseph S Pliskin; Itzhak Benenson; Erez Hatna; Asher Tal
Journal:  Int J Health Geogr       Date:  2006-01-17       Impact factor: 3.918

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.